PharmEasy ₹1700 Cr Loan Explained

UnlistedZone Research

Research desk

1 min read

PharmEasy raises ₹1,700 crore to repay its Goldman Sachs loan. Will this move stabilize the company and boost investor confidence? Watch the full story on UnlistedZone.

Disclaimer: This article is for informational purposes only and is not investment advice, nor an offer to buy or sell any security. Unlisted share prices are indicative. Please do your own research or consult a SEBI-registered advisor before investing.